Page 213 - Aet News Today

As we look out over the horizon to 2023, we would anticipate a rebound of investment in the digital health space but with a simultaneous and a continuing level of focused regulatory diligence as this complex landscape continues to evolve.

Never has there been a time in healthcare when listening and understanding have been more critical. Issues of today are divisive, complex, and layered without easy solutions. We cannot possibly begin to fix without slowing down to listen through every channel available.

AI chatbots and automated responses are great tools for service providers to leverage when it comes to improving efficiency in customer service. However, while working in health tech with a focus on nutrition support, I have found that many providers lack an element of human connection that you can’t attain as easily from a chatbot. If you want to speak with a real expert 1:1 to help better understand how to take back control of your wellness and improve your health, human connection is one o...

The first regulatory approval of an allogeneic cell therapy goes to Atara Biotherapeutics. Other regulatory news highlights from the past week include proposed reforms of the FDA’s accelerated approval process, approval of the first gene therapy for bladder cancer, and a clinical hold for a biotech developing a new class of medicines.

Blue Cross and Blue Shield of Minnesota formed a value-based arrangement with Minnesota Oncology in 2019. Preliminary data show that it led to a reduction in the total cost of care, emergency visits and inpatient admissions.

The future towards the safer treatment of pain will come as biopharma, and investor communities appreciate the significant opportunities in supporting scientifically rigorous and clinically validated lead assets for the safer treatment of pain.

I write this because of my own personal experience with stealing prescription drugs while employed as a nurse, which led to me serving a four-month jail sentence and losing the career of my dreams.

Inflation and shrinking operational margins are among the key factors that will influence hospitals and health systems’ strategies in 2023. To deal with this, more hospitals will merge with other systems, predicted Tina Wheeler, Deloitte’s leader for its healthcare sector.

Many providers think their telehealth program increases the workload for nurses and support staff, according to a recent report. In 2023, hospitals and physician practices will have to focus on making their telehealth workflows more efficient, which may involve partnering with third-party administrators.

Nearly 90% of Americans prefer to receive their health coverage through an employer versus other means, according to a new survey. Quality, affordability and convenience are the key reasons for why Americans favor employer-sponsored insurance.